Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

This study has been completed.
Sponsor:
Collaborator:
Astex Pharmaceuticals
Information provided by:
Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier:
NCT00144430
First received: August 31, 2005
Last updated: February 2, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):